Shenzhen TungTakSim Biotech Co., Ltd. is a research-driven company dedicated to life sciences and collaborative academic research. The company is committed to advancing the translation of traditional herbal practices into modern life science applications. Starting from long-term real-world observations and supported by clinical trials, peer-reviewed publications, independent third-party laboratory reports, animal studies, and mechanistic research, the company has established a verifiable, reproducible, and translatable scientific research framework. Its research focuses on major medical challenges, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), pathogen inhibition, antimicrobial resistance and treatment outcomes, immune regulation, anti-hemolytic mechanisms, and the restoration of biological homeostasis. Rather than operating as a conventional product-oriented company, Shenzhen Tongdexin Biotech is founded on the holistic principles of Eastern medicine and seeks to reinterpret the scientific value of herbal nutrition through the language and methodology of modern biomedicine. The company strives to achieve breakthrough research in the fields of anti-infective strategies, immune reconstruction, organ protection, and regenerative life sciences. Looking ahead, Shenzhen Tongdexin Biotech will continue to collaborate with universities, hospitals, research institutions, and leading scientific experts to promote the scientific validation, standardization, and internationalization of herbal nutrition research.

Over the past two decades, global medicine has faced unprecedented challenges and breakthroughs due to objective reasons. The challenges stem from the gradual inefficacy of antibiotics, the exponential increase in superbugs, and the growing and widespread drug resistance in the human body. Severe viruses without vaccines or specific treatments emerge constantly, and mainstream medicine struggles to cope with rare diseases, chronic illnesses, terminal conditions, and diseases lacking effective vaccines and drugs—these symptoms threatening human health are erupting at an exponential rate. Even with the assistance of big data and significant social resources, mainstream medicine still cannot effectively address these human crises.
In contrast, the core theory of traditional Chinese medicine is rooted in the human body as a universe, emphasizing the inherent balance of mutual generation and restraint. Due to the advanced scientific logic of Chinese medicine, current mainstream science, data, and computational power cannot comprehend or recognize the cosmic scientific logic embedded in Chinese medicine. This has led to a modern consensus in mainstream medicine and among the public: Chinese medicine is not a medical science but merely a culture. This is an absurd concept. In fact, the latest advancements in mainstream medicine—such as the understanding of cells, in-depth research on human DNA, the targeted therapy theory of small molecules, and exosome interventions—are gradually aligning with the scientific cosmic balance principles of Chinese medicine, giving rise to so-called personalized treatment. Based on in-depth research and judgment of traditional medical science and modern science, our team firmly believes that future science will increasingly recognize the greatness and importance of Chinese medical science.
However, due to the hegemony of modern medicine over medical science, coupled with the impact of modern computational power, if Chinese medical science cannot obtain effective validation from modern science, it will face a second marginalization following the antibiotic era, fraught with crises.
Since 2003, Hong Kong Tong De Xin Dietary Therapy Company has conducted breakthrough research on the bottlenecks faced by mainstream science in dietary nutrition, human immunity, cells, intestines, bacteria, viruses, drug resistance, and rare diseases, achieving some clinical results in the real world. However, due to the severe lag in relevant talent and resources in Hong Kong's real-world research practice compared to the resource endowments and scientific innovation spirit on the mainland, we decided to establish an academic clinical research company in the life sciences field in Shenzhen based on existing real-world scientific and technological achievements. Utilizing the great scientific innovation spirit, abundant talent resources, and innovative research momentum on the mainland, we collaborate with relevant authoritative institutions to tackle the bottlenecks in human life and health medicine. In 2022, we established Shenzhen Tong De Xin Biological Technology Co., Ltd. in Guangming Science City.
The contemporary medical science community has long been dominated by the Western medical knowledge system, forming a strong scientific monopoly in both research and public perception. However, the real world of human health presents another severe situation: as science continues to develop, chronic diseases, intractable diseases, drug resistance, bacterial and viral diseases, immune disorders, and rare diseases are increasing at a rate surpassing the development of mainstream medical science. Superbugs, viruses, and rare diseases lack highly effective drugs, and conventional human health is facing a severe crisis.
Based on the realistic crises revealed by the current medical state, human social systems and the mainstream medical science community are leveraging the significant advancements in big data technology to actively seek pathways to break through the current predicament. Consequently, various medical technology development and research institutions are emerging worldwide, presenting a stage of fair competition with diverse schools of thought and flourishing innovations.
However, large-scale medical research investments have failed to halt the continuous progression and increasing prominence of chronic diseases, intractable diseases, cancer, and rare diseases. Additionally, advanced data research has not been efficiently applied to the human body. This indicates that the foundational theories of Western mainstream medical science may have serious deficiencies and gaps. When the root theoretical foundation of research itself is problematic, even with the strong support of big data and other advanced technologies, it is difficult to truly resolve the current medical crisis.
The core viewpoint of traditional medical science theory is the "balance principle." Human health is fundamentally based on the conventional healthy balance state formed by the mutual functional interactions from precise single cells to organ systems and the entire body. Its existing scientific evidence, along with the long-standing cognitive and treatment methods of nutrition and drugs that combine precise treatment with overall balance characteristics, is the only and most ideal scientific and technological system for human health science theory to break out of the current medical predicament.
The emergence of big data has provided new assistance to experts in Chinese and Western medicine research and medical research institutions, promoting the continuous breakthrough of data-driven research models in traditional Eastern medicine. This has gradually enabled it to gain recognition and acceptance in the medical science community in terms of real-world symptom results and data statistical science. Today's global medical field presents a pattern of multi-path exploration and diverse schools of thought, providing a new era opportunity for Eastern medical science to break out of long-term data dilemmas and gain fair competition opportunities.
The human body is an extremely complex infinite cosmic body. Over the past three hundred years, Western medicine, along with today's big data technology, has overall remained primarily within the framework of precision medicine. However, the various local manifestations of the human body are often just external presentations of the overall state. Even if precision medicine can precisely identify, intervene, and control individual phenomena, it is often only effective but incomplete, exhibiting more phased and symptomatic characteristics, prone to recurrence, and difficult to achieve true comprehensive cure. This also indicates that unilateral precision medicine has inherent limitations at the conceptual level.
Meanwhile, the precise targeting concepts emphasized by Eastern medicine, such as entering the brain, heart, liver, kidneys, resolving stasis, expelling dampness, and dispelling wind, as well as the overall support and state views, can also be analyzed and explained using modern medical language. However, limited by the current medical cognitive framework and the boundaries of big data statistical capabilities, we have not yet been able to fully and systematically present the overall mechanisms of Eastern medicine and its potential complementary relationship with precision medicine in a scientific manner.
This is our team's preliminary understanding and analysis of the current medical situation. Precisely because today's medical development is in an era of diverse schools of thought and flourishing innovations, this provides our team with important scientific opportunities and development space to continue deepening the research on the core concepts of Eastern medicine.